"Health Secretary Robert F. Kennedy Jr. expressed optimism about the FDA changing the status of 'about 14' peptides, potentially allowing consumer access from ethical suppliers within weeks."
"Peptides, smaller than proteins, are naturally produced by the body and have gained interest for their purported benefits in tissue repair, skin health, and longevity."
"Currently, the FDA prohibits compounding pharmacies from making popular peptides like BPC-157 and ipamorelin due to safety concerns and insufficient data."
"Peptide enthusiasts often resort to purchasing these compounds from overseas or unregulated websites, as they seek access to the benefits of these therapies."
Health Secretary Robert F. Kennedy Jr. indicated that the FDA might soon change the status of about 14 peptides, allowing access from ethical suppliers. Peptides, which are strings of amino acids, have gained popularity for their potential benefits in tissue repair, skin health, and longevity. Currently, the FDA restricts compounding pharmacies from making popular peptides due to safety concerns. The FDA aims to ensure quality standards for products, but no specific timeline for reclassification has been provided.
Read at www.npr.org
Unable to calculate read time
Collection
[
|
...
]